Edwards Lifesciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2,686	3,045	1,132	769	862.8	1,183
Short-Term Investments	1,156	930.7	500.5	446.3	604	219.4
Cash & Short-Term Investments	3,842	3,976	1,633	1,215	1,467	1,403
Cash Growth	-13.59%	143.50%	34.35%	-17.15%	4.58%	-7.54%
Accounts Receivable	693.3	609.1	771.5	643	582.2	514.6
Other Receivables	199.5	118.3	56.6	56.1	82.7	88.2
Receivables	892.8	727.4	828.1	699.1	664.9	602.8
Inventory	1,141	1,087	903.5	875.5	726.7	802.3
Prepaid Expenses	125.2	121	128.8	110	85.2	75.1
Restricted Cash	0.7	3.2	3.3	0.5	1.5	16.6
Other Current Assets	357.3	371.2	539.2	195.4	235.6	191.6
Total Current Assets	6,359	6,285	4,036	3,096	3,181	3,091
Property, Plant & Equipment	1,840	1,784	1,675	1,725	1,639	1,489
Long-Term Investments	274.7	307.9	583.9	1,239	1,834	801.6
Goodwill	1,769	1,777	1,145	1,164	1,168	1,173
Other Intangible Assets	1,131	1,177	399.4	285.2	323.6	331.4
Long-Term Deferred Tax Assets	1,100	992.1	749.4	484	246.7	230.9
Other Long-Term Assets	572.3	603.1	619.2	299.1	110.8	119.6
Total Assets	13,272	13,055	9,363	8,293	8,503	7,237
Accounts Payable	165	197.4	186.6	201.9	204.5	196.5
Accrued Expenses	907.7	790.4	667.2	593.1	643.4	516
Current Portion of Leases	26.8	23.4	22.9	25.5	25.5	27.2
Current Income Taxes Payable	129.5	286.6	52.7	50.6	30.6	18.6
Current Unearned Revenue	33.2	53.7	-	-	-	-
Other Current Liabilities	325.8	153.7	266	151.3	128.3	135.6
Total Current Liabilities	1,588	1,505	1,195	1,022	1,032	893.9
Long-Term Debt	598.2	597.7	597	596.3	595.7	595
Long-Term Leases	75.3	78.9	65.2	69.5	69.1	72.7
Pension & Post-Retirement Benefits	-	32.1	36.2	23.5	41	52.9
Other Long-Term Liabilities	758.6	778.5	750	774.1	928.6	1,048
Total Liabilities	3,067	2,992	2,644	2,486	2,667	2,663
Common Stock	658.2	654.8	650.5	646.3	642	636.4
Additional Paid-In Capital	2,697	2,613	2,274	1,969	1,700	1,438
Retained Earnings	14,149	13,167	8,992	7,590	6,068	4,565
Treasury Stock	-7,050	-6,192	-5,025	-4,144	-2,417	-1,904
Comprehensive Income & Other	-250.4	-244.5	-242.8	-254.9	-157.7	-161.1
Total Common Equity	10,205	9,998	6,650	5,807	5,836	4,574
Minority Interest	-	64.5	69.4	-	-	-
Shareholders' Equity	10,205	10,063	6,719	5,807	5,836	4,574
Total Liabilities & Equity	13,272	13,055	9,363	8,293	8,503	7,237
Total Debt	700.3	700	685.1	691.3	690.3	694.9
Net Cash (Debt)	3,148	3,281	947.7	524	776.5	707.7
Net Cash Growth	-15.99%	246.25%	80.86%	-32.52%	9.72%	-15.56%
Net Cash Per Share	5.35	5.48	1.56	0.84	1.23	1.12
Filing Date Shares Outstanding	580.3	587.9	601.3	608.31	623.21	624.52
Total Common Shares Outstanding	580.7	588.6	601.1	608.3	624.1	624.3
Working Capital	4,771	4,780	2,840	2,073	2,148	2,197
Book Value Per Share	17.57	16.99	11.06	9.55	9.35	7.33
Tangible Book Value	7,306	7,045	5,106	4,357	4,344	3,070
Tangible Book Value Per Share	12.58	11.97	8.49	7.16	6.96	4.92
Land	-	123.9	112.4	116.3	116.5	97.6
Buildings	-	1,340	1,189	1,189	1,010	881.5
Machinery	-	689.4	618.6	735	652.6	607.1
Construction In Progress	-	244	292.5	255.2	333.8	313.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.